Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Swallowed Fluticasone Propionate in Eosinophilic Esophagitis
NCT00426283Phase 2Completed
- Start
- Jan 2007
- Primary completion
- Dec 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fluticasone propionate in eosinophilic esophagitis (EoE). Started Jan 2007; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT00426283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00426283.